Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia have?
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia has 3,287 citations in the OpenAlex counts ScholarIQ stores.
When was Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia published?
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia has 2018 year in the ScholarIQ index.
What is the open-access status of Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia?
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia has closed oa status in the ScholarIQ index.
What is the DOI of Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia?
The DOI for Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia is on the source record.
What is the PMID of Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia?
The PMID for Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia is on the source record.
What is the OpenAlex record for Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia?
The OpenAlex for Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia is on the source record.